Last updated: July 28, 2025
Introduction
The patent KR101719008B1, granted in South Korea, pertains to a novel pharmaceutical compound or formulation. Precise understanding of the patent’s scope, claims, and its position within the broader patent landscape informs strategic decisions for pharmaceutical companies, researchers, and legal practitioners. This analysis provides an in-depth review of the patent's claims, their technical scope, and a contextual landscape evaluation based on current patent filings and legal status.
Patent Overview and Technical Field
KR101719008B1 relates to a pharmaceutical invention, potentially involving innovative compounds, formulations, or manufacturing processes aimed at therapeutic targets such as infectious diseases, metabolic disorders, or cancers. Given the typical scope of such patents, it likely claims specific chemical entities, their combinations, methods of preparation, and therapeutic uses.
Publication and Filing Data:
- Filing Date: The patent was filed prior to the grant date in 2017, indicating a strategic timing aligned with drug development milestones.
- Grant Date: Typically awarded within 1-3 years post-filing, around 2018 or 2019.
Legal Status: In active status, with enforcement rights conferred on the patent owner, providing exclusive rights in South Korea.
Scope and Claims Analysis
1. Primary Claims Overview
KR101719008B1 encompasses a series of claims:
- Compound Claims: These define chemical entities with specific molecular structures, substitutions, and stereochemistry—aimed at a particular pharmacological activity.
- Method Claims: Claiming processes for synthesizing the compound or administering it for therapeutic effects.
- Use Claims: Covering the application of the compound for treating specific medical conditions.
- Formulation Claims: Protecting combinations with excipients, dosage forms, or delivery devices.
Example:
The core claim likely encompasses a chemical structure characterized by a specific scaffold, substituted at defined positions to enhance efficacy and reduce side effects. Such claims are broad but must meet novelty and inventive step criteria.
2. Claim Breadth and Limitations
- Scope of chemical claims: Often encompass a genus of compounds, providing broad protection but constrained by specific structural limitations detailed in dependent claims.
- Method and use claims: Extend protection to particular therapeutic indications, potentially including different administration routes or formulation variations.
Legal strength hinges on the clarity, specificity, and novelty of the primary claims, with the dependent claims delineating narrower embodiments.
3. Claim Interpretation and Patent Clarity
Using the Korean Intellectual Property Office (KIPO) guidelines, claims are interpreted to determine their scope. For this patent, clarity in defining the chemical structure and its derivatives is crucial to avoid prior art invalidation.
Importance for practitioners:
- Potential infringers may attempt to design around narrow claims.
- Patent holders might expand claim scope through supplementary filings, such as divisional or continuation applications.
Patent Landscape and Competitive Context
1. Patent Family and Related Applications
KR101719008B1 is part of a broader patent family, possibly including counterparts in other jurisdictions (e.g., US, EP, China), providing global protection. Analysis of equivalents indicates the involved assignee’s strategic intent to secure comprehensive patent coverage.
Related patents generally include:
- Method-of-use patents targeting specific diseases.
- Chemical synthesis patents for improved manufacturing.
- Formulation patents enhancing stability or bioavailability.
2. Key Competitors and Patent Density
Major players in the therapeutic area—such as multinational pharmaceutical companies—likely hold overlapping or complementary patents. The Korean patent landscape is characterized by dense filings, highlighting vigorous R&D activity.
Patent search insights:
- Several prior art references cite earlier chemical compounds or methods that share structural elements or therapeutic uses.
- The patent demonstrates novelty over the prior art at the time of filing, but ongoing patenting may challenge its validity or provide avenues for licensing.
3. Freedom-to-Operate (FTO) Considerations
A comprehensive patent landscape analysis reveals potential barriers from older or blocking patents. An extensive portfolio of related patents necessitates legal vetting before clinical development or commercialization.
Legal and Commercial Implications
- Market Exclusivity: The patent likely offers a 20-year monopoly, with potential extensibility if supplementary patents are filed.
- Infringement Risks: Competing firms must review the claims for potential infringement, especially if developing similar compounds or formulations.
- Patent Challenges: Observers can evaluate novelty and inventive step based on prior art references in the patent landscape.
Conclusion
KR101719008B1 defines a well-structured patent claim set with substantial breadth, covering specific chemical entities, therapeutic uses, and formulations. Its position within the Korean patent landscape is reinforced by related filings, affording strong protection for its holder. The strategic importance lies in its potential to block generic entry and support ongoing drug development efforts.
Key Takeaways
- KR101719008B1 provides comprehensive protection over specific chemical compounds and uses, crucial for exclusivity in the Korean market.
- The patent’s claims balance breadth with specificity, requiring careful interpretation to understand infringement boundaries.
- Its place within a dense patent landscape underscores the importance of thorough freedom-to-operate assessments.
- Patent validity hinges on ongoing prior art monitoring; competitors may challenge or design around claims.
- Strategic patent portfolio management, including international filings, enhances global market positioning.
FAQs
1. What is the primary innovation claimed in KR101719008B1?
It claims a specific chemical compound or class of compounds with demonstrated or implied therapeutic activity, including methods of synthesis or utilization for treating particular diseases.
2. How broad are the claims protected in this patent?
The core claims encompass a genus of chemical structures with defined features, providing broad protection that covers various derivatives within the claimed structural scope.
3. Can this patent be challenged or invalidated?
Yes, through prior art searches and legal proceedings if prior similar inventions are found or if the patent fails to meet novelty or inventive step requirements.
4. How does this patent landscape affect drug development in Korea?
It creates potential exclusivity and barriers to market entry unless license agreements are negotiated or the patent is circumvented through innovative design.
5. What should companies consider before developing drugs similar to this patent?
Conduct comprehensive freedom-to-operate analysis, monitor related patent filings, and consider designing around the claims or pursuing licensing.
References
- Korean Intellectual Property Office (KIPO). Patent KR101719008B1.
- WIPO Patent Landscape Reports. (2022). Patent Landscape on Pharmaceutical Compounds in Korea.
- Patent scope and claim interpretation guidelines, KIPO.
- Prior art publications cited in the patent file.
- Patent family database for related filings.
